Yingkai Tao
Changzhou, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Biocompatible Mesoporous Silica-Polydopamine Nanocomplexes as MR/Fluorescence Imaging Agent for Light-Activated Photothermal-Photodynamic Cancer Therapy In Vivo.
Journal: Frontiers in bioengineering and biotechnology
Published: August 04, 2021
Near-Infrared Light-Triggered Thermosensitive Liposomes Modified with Membrane Peptides for the Local Chemo/Photothermal Therapy of Melanoma.
Journal: OncoTargets and therapy
Published: October 16, 2020
CD44-Targeting Oxygen Self-Sufficient Nanoparticles for Enhanced Photodynamic Therapy Against Malignant Melanoma.
Journal: International journal of nanomedicine
Published: September 27, 2020
Near-infrared laser-induced phase-shifted nanoparticles for US/MRI-guided therapy for breast cancer.
Near-infrared laser-induced phase-shifted nanoparticles for US/MRI-guided therapy for breast cancer.
Journal: Colloids and surfaces. B, Biointerfaces
Published: April 17, 2020
Application of nanoparticle-based siRNA and CRISPR/Cas9 delivery systems in gene-targeted therapy.
Journal: Nanomedicine (London, England)
Published: February 27, 2019
Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma.
Journal: Cancer medicine
Published: April 23, 2018
Nanoparticle-based photothermal and photodynamic immunotherapy for tumor treatment.
Journal: International journal of cancer
Published: March 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026